Teladoc Health, Inc. (TDOC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TDOC Revenue Growth
Revenue Breakdown (FY 2025)
TDOC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
TDOC Revenue Analysis (2014–2025)
As of May 7, 2026, Teladoc Health, Inc. (TDOC) generated trailing twelve-month (TTM) revenue of $2.51 billion, reflecting slight decline in growth of -2.5% year-over-year. The most recent quarter (Q1 2026) recorded $613.8 million in revenue, down 4.4% sequentially.
Looking at the longer-term picture, TDOC's 5-year compound annual growth rate (CAGR) stands at +18.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $2.60 billion in 2023.
Revenue diversification analysis shows TDOC's business is primarily driven by Other (100%). With over half of revenue concentrated in Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including AMWL (-30.3% YoY), HIMS (+59.0% YoY), and DOCS (+15.9% YoY), TDOC has underperformed the peer group in terms of revenue growth. Compare TDOC vs AMWL →
TDOC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TDOCCurrent | $2.5B | -2.5% | +18.3% | -10.4% | |
 AMWL | $249M | -30.3% | +0.3% | -42.2% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 DOCS | $570M | +15.9% | +37.4% | 39.9% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 OMCL | $1.2B | +7.9% | +5.8% | 0.4% |
TDOC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.53B | -1.5% | $1.76B | 69.5% | $-262,955,000 | -10.4% |
| 2024 | $2.57B | -1.3% | $1.82B | 70.8% | $-1,020,886,000 | -39.7% |
| 2023 | $2.60B | +8.1% | $1.84B | 70.8% | $-248,553,000 | -9.6% |
| 2022 | $2.41B | +18.4% | $1.66B | 69.1% | $-13,653,214,000 | -567.3% |
| 2021 | $2.03B | +85.8% | $1.38B | 68.0% | $-265,630,999 | -13.1% |
| 2020 | $1.09B | +97.7% | $703.1M | 64.3% | $-506,421,000 | -46.3% |
| 2019 | $553.3M | +32.4% | $368.8M | 66.7% | $-80,442,000 | -14.5% |
| 2018 | $417.9M | +79.1% | $289.2M | 69.2% | $-70,854,000 | -17.0% |
| 2017 | $233.3M | +89.4% | $171.7M | 73.6% | $-75,394,000 | -32.3% |
| 2016 | $123.2M | +59.2% | $91.2M | 74.0% | $-62,664,000 | -50.9% |
See TDOC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TDOC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TDOC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTDOC — Frequently Asked Questions
Quick answers to the most common questions about buying TDOC stock.
Is TDOC's revenue growth accelerating or slowing?
TDOC revenue growth slowed to -2.5%, below the 5-year CAGR of +18.3%. TTM revenue is $2.5B. The deceleration marks a shift from historical growth rates.
What is TDOC's long-term revenue growth rate?
Teladoc Health, Inc.'s 5-year revenue CAGR of +18.3% reflects the variable expansion pattern. Current YoY growth of -2.5% is near this long-term average.
How is TDOC's revenue distributed by segment?
TDOC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.